We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $1.26B
1-Year Est. Return 95.39%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+95.39%
3 Year Est. Return
+360.87%
5 Year Est. Return
+519.82%
10 Year Est. Return
+3,025.56%
AUM
$892M
AUM Growth
-$93.5M
Cap. Flow
-$101M
Cap. Flow %
-11.37%
Top 10 Hldgs %
31.04%
Holding
390
New
36
Increased
60
Reduced
190
Closed
62

Top Buys

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$12M
2
STX icon
Seagate
STX
+$10.9M
3
UI icon
Ubiquiti
UI
+$6.46M
4
IDXX icon
Idexx Laboratories
IDXX
+$5.31M
5
NVT icon
nVent Electric
NVT
+$4.54M

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$12.7M
2
AXON
Axon Enterprise
AXON
+$10.2M
3
PGR icon
Progressive
PGR
+$9.78M
4
NTNX icon
Nutanix
NTNX
+$6.04M
5
AROC icon
Archrock
AROC
+$5.73M

Sector Composition

Rank Sector Weight
1 Technology 26.86%
2 Industrials 23.46%
3 Healthcare 10.94%
4 Materials 8.12%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTI icon
376
Universal Technical Institute
UTI
$2.31B
-142,418
Closed -$4.64M
VEU icon
377
Vanguard FTSE All-World ex-US ETF
VEU
$68.1B
-4,333
Closed -$309K
WLFC icon
378
Willis Lease Finance
WLFC
$1.63B
-13,479
Closed -$616K
XLF icon
379
State Street Financial Select Sector SPDR ETF
XLF
$58.7B
-15,420
Closed -$831K
XLY icon
380
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23B
-9,100
Closed -$1.09M
YOU icon
381
Clear Secure
YOU
$5.98B
-42,224
Closed -$1.41M
MRX
382
Marex Group Limited Ordinary Shares
MRX
$4.67B
-7,655
Closed -$257K
AAMI
383
Acadian Asset Management
AAMI
$3.26B
-6,446
Closed -$310K
SVA
384
DELISTED
Sinovac Biotech, Ltd
SVA
$0 ﹤0.01%
13,018
-550
-4%

Similar funds

Navellier & Associates's Q4 2025 Portfolio in Review

As of Q4 2025, Navellier & Associates held 390 positions worth $892M, down 9.5% from $986M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Navellier & Associates withdrew a net $101M in Q4 2025, closing 62 positions and reducing 190 holdings. Its most notable exit was Axon Enterprise, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Navellier & Associates opened a new position in Cardinal Health worth $13.1M.

  • Navellier & Associates's largest Q4 2025 buy was Cardinal Health: 63,768 shares worth $13.1M.
  • Navellier & Associates added most to Ubiquiti in Q4 2025, an estimated $6.46M increase.
  • Navellier & Associates's biggest Q4 2025 reduction was Costco, cutting an estimated $12.7M.
  • Navellier & Associates fully exited Axon Enterprise in Q4 2025, selling an estimated $10.2M.
  • Navellier & Associates's ten largest holdings make up 31% of its $892M portfolio in Q4 2025.
  • Navellier & Associates opened 36 new positions and closed 62 in Q4 2025.
  • Navellier & Associates's portfolio value fell 9.5% quarter-over-quarter to $892M.

Based on Navellier & Associates's 13F filing for Q4 2025, filed 3 Feb 2026.